STOCK MARKET BSE NSE

Effective vaccine against coronavirus would not be available in the near future: Experts

Vaccines with proven efficacy and safety, as and when available, should be administered according to the WHO's 'strategic allocation' approach or a multi-tiered risk-based approach.

Published: 01st September 2020 11:07 AM  |   Last Updated: 01st September 2020 11:33 AM   |  A+A-

This undated handout photo provided by Imperial College London shows a COVID-19 vaccine candidate. Scientists at Imperial College London will start immunizing people in Britain this week with their experimental coronavirus shot, becoming the latest entry

For representational purposes (Photo | AP)

By PTI

NEW DELHI: Public health experts and doctors, including those from AIIMS and ICMR's National Task Force on COVID-19 have said it must be assumed that an effective vaccine against coronavirus "would not be available in the near future" and any false sense of hope that this panacea is just around the corner must be avoided.

In a a joint statement submitted to the prime minister, experts of Indian Public Health Association (IPHA), Indian Association of Preventive and Social Medicine (IAPSM) and Indian Association of Epidemiologists (IAE) have said while being optimistic, the prevention and control strategy should also prepare for the worst.

"Vaccines have no role in current ongoing pandemic control. However, whenever available, the vaccine may play a role in providing personal protection to high-risk individuals like Healthcare workers (HCWs) and elderly with comorbidities," the experts said.

"It must be assumed that an effective vaccine would not be available in near future. We must avoid false sense of hope that this panacea is just around the corner," they said.

Vaccines with proven efficacy and safety, as and when available, should be administered according to the WHO's "strategic allocation" approach or a multi-tiered risk-based approach.

Vaccines may theoretically be a useful intervention in future, if and when made available for public health use, the experts said, highlighting many countries, including Russia and China, are fast-tracking the vaccine development which might have concerns of efficacy and safety.

Highlighting that the ongoing pandemic is a public health problem that is fast worsening the existing health inequities, and not a law and order problem, the experts stressed that it should be dealt with empathy and meaningful community engagement.

The way forward needs to take into account contextual constraints and community interests and design optimal interventions that require technical competence blended with good judgment, clarity and trust, they said.

State and district level epidemiologists would have been an excellent resource to interpret the data locally, and suggest context specific response, the experts said.

"However, these posts are mostly lying vacant due to poor salary structure. There is an urgent need to declare their posts as specialist post requiring MD degree in Community Medicine or Preventive and Social Medicine and recruit qualified persons," they said.

Experts also recommended said that state and national level serosurveillance surveys need to be undertaken to monitor the pandemic and modify the control strategies accordingly.

In future use of already existing sero-surveillance platform could be a cost-effective way to do the sero surveillance.

All the sero surveillance must be supervised by trained public health specialists (MD Community Medicine) from local medical colleges, and public health institutions, they said.

Experts also recommended that role of front-line community health workers in COVID-19 control activities needs to be acknowledged and due recognition given to these front line COVID-19 warriors.

"This will not only boost the efforts of prevention and control of epidemic in the field but also community at a large will realize the importance of preventive measures and join hands in efforts for with government in prevention and control," they said.

The 20-member joint COVID Task Force includes Dr Shashi Kant, past president IAPSM, and Head of the Centre for Community Medicine at AIIMS, New Delhi, Dr Sanjay K Rai, national president, IPHA and Professor, CCM,  AIIMS, Dr Kapil Yadav, additional professor, CCM, AIIMS, New Delhi, Dr Sujeet Kumar Singh, Director of National Centre for Disease Control NCDC), Dr D C S Reddy, former professor and head, Community Medicine, IMS, BHU, Varanasi and Dr. Rajesh Kumar, former Professor and Head, DCM &SPH, PGIMER, Chandigarh.

Dr Singh and Dr Kant are members of ICMR National Task Force on COVID-19 while Dr Reddy chairs the ICMR research group on epidemiology and surveillance for COVID-19.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp